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1. Introduction 
The production of proteins by recombinant micro-organisms has been possible since the late 
70’s. Since then enormous steps have been made to improve protein titers and to expand the 
range of possible proteins to be produced. The development of genetic modification tools 
and improved ease of use of cloning strategies have played an important role in this. The 
time to construct a strain and develop a cost-effective bioprocess has decreased significantly. 
Concurrently, sequencing data, which serve as a library for donor genes to be 
overexpressed, have increased exponentially. Therefore, the speed and flexibility to engineer 
custom-made protein factories has improved tremendously during the last decades. As in 
any developed technology, a certain degree of standardization is desired. In order to make 
this ambition more tangible the concept of cell factories is often used. This concept is based 
on the principle that the cell factory should be able to produce any protein to a certain 
desired level. Based on the concept of standardized expression vectors and expression hosts 
the basics of this cell factory concept were built. However, in reality this concept proved  
to be far too simple, as a standardized input does not result in a standardized output.  
This is caused by the immense complexity and dynamics of cellular systems. Even  
when all components are described, by sequencing the genome, the interaction, 
compartmentalization and dynamics of these components are largely unknown. A striking 
example is the difference between homologous protein expression which are produced to 
levels up to 50 g/l in filamentous fungi whereas heterologous proteins are produced at 
levels which are usually 100-1000 fold less 1. So even when identical tools are used in a 
standardized approach the final result can vary over several orders of magnitude. 
The general consensus is that this large difference is linked to cellular events and responses  
which are caused by the overexpression of the heterologous proteins 2, therefore the 
scientific community, together with biotech industries, have been studying these effects for 
several decades. The cellular stress responses and intracellular events which are linked to 
the use of cells as protein production factories are very well described 3-9. This profound 
insight in the molecular mechanism of the cellular stress reactions has facilitated the 
increase in expression and secretion levels of some heterologous proteins. However, levels 
comparable to homologous proteins have not been reached 1, 10. It is evident that, when even 
more demanding sources of biodiversity are tapped, like intracellular proteins, the 
engineering of a robust and versatile cell factory which is able to produce this wide range of 
proteins becomes a major challenge.  
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The production of intracellular proteins in a secreted form, to avoid complex and costly 
downstream processing, has hardly been touched upon. Several strategies have been 
developed to increase protein titers, however, these efforts have all been focused on 
secreted proteins. The functional diversity of intracellular proteins is very broad, while 
extracellular enzymes are mostly hydrolases, as shown in Figure 1. If the cell would be 
able to secrete these intracellular enzymes in an active form a wide range of applications 
could be within reach. Current strategies do not suffice but when these are combined with 
membrane engineering to redirect vesicle trafficking this could become a very promising 
approach. 
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Fig. 1. Distribution of enzyme functionalities in Aspergillus niger. The genome sequence of 
Aspergillus niger was mined for annotated functionalities based on EC classifications. The 
extracellular (extra) or intracellular (intra) protein distribution is based on this annotated 
genome. The left panel indicates relative function distribution, the right panel shows 
absolute numbers of enzyme function distribution. 
This chapter will discuss the different strategies to improve the productivity of the cellular 
protein factory. Especially the possibility of engineering membrane trafficking will be 
addressed. This technology is not only useful for developing a versatile and robust cell 
factory but can be very valuable to study intracellular membrane trafficking on an academic 
level as well. 
2. Conventional engineering strategies for improved protein production 
The conventional strategy to improve protein production is to increase the expression levels 
of the gene of interest by using multiple gene copies and strong promotors 11, 12. As a 
consequence, the cell is faced with very high levels of mRNA which should rapidly be 
translated into active and correctly folded proteins. To handle this increased demand for 
folding capacity the cell often reacts with the so called Unfolded Protein Response (UPR). 
This UPR is a well studied mechanism 13-17 which is also applied to increase folding 
capacity. By upregulating the transcription factors needed, or the resulting chaperones and 
folding enzymes, the folding capacity of the cell is enhanced 18-21.  
www.intechopen.com
 
Peroxicretion, a Novel Tool for Engineering Membrane Trafficking 
 
139 
For heterologous proteins the fusion peptide concept has been proven to be successful 22. 
This concept is used for heterologous proteins which are secreted by their native host but 
are overexpressed in an alternative system to increase production titers. By fusing the 
protein of interest to a homologous protein which is naturally secreted by the host, the 
desired protein is also transported outside the cell, for example, Acremonium murorum 
phenol oxidase expressed in Aspergillus awamori 23. This carrier protein is often an N –
terminal part of a very well secreted homologous protein which is fused to the protein of 
interest. Often a cleavage site is engineered, like Kex2 with the aim to produce only the full 
length protein. In reality often a mixture of unprocessed protein, partially processed protein 
and fully processed protein is produced, which can have consequences for downstream 
processing in order to meet the required product specifications. On the other hand, there are 
also reports which describe secretion of heterologous proteins by using only signal 
sequences without any additional fusion proteins like the production of llama variable 
heavy-chain antibody fragments (VHHs) 24 and the production of Arthromyces ramosus 
peroxidase 25 both in Aspergillus awamori. However, the titers obtained by these systems are 
in the mg/l range which is generally not sufficient for an economically feasible process.  
The next generation of tools to increase protein titers are based on technology developments 
within bio-IT combined with the possibility of designing custom-made genes. Recently, the 
concept of codon adaptation was demonstrated. This concept is based on the use of 
favorable codons so that translation of the mRNA encoding the protein of interest is not a 
bottleneck. An excellent in silico study has recently been published 26 describing that 
translational speed and, concomitantly, ribosome density are determined by the 
combination of coding sequences and the tRNA pool. The first dozens of codons are 
translated at lower rates and create an area where ribosomes are very densely packed, 
especially on transcripts with a high mRNA level. This strategy could prevent ribosome 
jamming in later stages of the translational process and therefore be of physiological 
advantage of the cell. This elevation of translational speed towards the end of transcripts is 
often seen in fungi (which are biotechnological work-horses) and provides the cell with an 
effective tool against late abortions of protein synthesis which is an energy-consuming 
process. As suggested by the authors the fine-tuning of this ramping principle could be an 
additional tool to increase the efficiency of the protein production factory. 
As optimizing codon usage is aimed at improving the translation of mRNA into protein, the 
folding capacity of the cell can become limiting, especially when high copy numbers and 
strong promoters are combined with codon optimization. The folding and refolding of 
proteins is tightly linked to membrane trafficking, a very stringent quality control system 
existing in the endoplasmic reticulum acts as a gatekeeper for proteins to be transported 
further into the secretory pathway. This quality control system has been reviewed recently 2. 
Also the removal of proteolytic activity has been applied to improve protein production 27-33 
this approach has shown to be very effective in specific cases. The success of the different 
approaches is hard to predict and highly dependent on the protein of interest being 
overproduced. In addition, all of the strategies above are focused to improve secretion of 
natural secreted proteins, most of them being hydrolases.  
An overview on conventional strategies to improve the productivity of the cellular protein 
factory is shown in Figure 2. As shown, the modification of DNA, which includes cloning 
strong promotors in front of the gene of interest and constructing multiple copies of this 
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expression cassette is a generic strategy which can lead to improvement of protein 
production. Also the optimization of codon(pair) usage and mRNA stabilizing elements can 
be applied in a generic way. The adaptation of the folding capacity of the host cell is not a 
generic approach. The folding and modification of proteins is intertwined and very protein 
specific. Improvement of regular transport of secretory vesicles is a strategy which is less 
well-known, but some possible routes have been described 34. In addition the 
overexpression of SEC4, a Rab protein associated with vesicles, doubled protein production 
in Pichia pastoris 35, which is a direct proof that modification of vesicle flow can result in 
enhanced protein production. However all these approaches are focused on enhancing the 
efficiency of existing protein production and secretory processes in the host cell. 
 
Fig. 2. Conventional improvement options for protein secretion in biological processes. 
Indicated in blue are the major steps in biological (eukaryotic) systems which are crucial for 
protein secretion, indicated in orange are improvement strategies which can be applied at 
the different stages of the protein secretion process. 
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3. Limitations of conventional strategies 
The conventional strategies described above are focused on incremental improvement, 
overproducing proteins which are naturally secreted products. Therefore, the large diversity 
of intracellular proteins remains untapped. In addition, these strategies can be seen as 
generic, at least in part, but very large differences in secretion efficiency exist between 
different proteins; changes of a few amino acids can often have a detrimental effect on 
protein secretion 7, 36. This is probably linked to different interactions with chaperones and 
folding enzymes. In the case of cutinase secretion in yeast, the bottleneck was circumvented 
by engineering an N-glycosylation site at the amino terminus of cutinase 8. The restrictions 
of conventional strategies are not only illustrated by the order of magnitude of differences in 
protein secretion but also by the limited class of proteins which are secreted. As shown in 
Figure 1, in A. niger most of the secreted proteins are hydrolases whereas the enzyme 
variation of intracellular enzymes is much larger. This enormous potential of enzymes is 
hardly being touched upon. There are strategies to overproduce intracellular proteins inside 
the cell but this is always followed by a complex downstream processing step to liberate the 
proteins and to purify them to an acceptable level 37, 38. In addition, toxic proteins or 
compounds cannot be produced by these methods at economical levels because they will 
very likely damage the host cell 39-41. In order to get access to the large variety of 
intracellular functionalities and to be able to produce toxic compounds into a cell 
compartment which does not impact the viability of the host cell, an additional strategy 
based on membrane engineering would be very valuable. 
4. Engineering membrane trafficking as a novel concept 
Whereas the conventional approaches are focused on reaching high levels of active proteins, 
the engineering of membrane trafficking is aimed at redesigning the membrane trafficking 
in the host cell enabling a custom made flow of vesicles which can expand the possible use 
of the microbial cell factory. This designed vesicle flow will give access to the large diversity 
of intracellular enzyme activities and will be important to produce toxic compounds 
without damaging the host cell.  
Recently a novel strategy was described to engineer membrane trafficking, this concept is 
called peroxicretion 42. The peroxicretion concept of engineering membrane trafficking is 
based on two features: 1) the use of cytosolic domains of SNARE proteins (soluble NSF (N-
ethylmaleimide-sensitive factor) attachment receptor) which are key for specific membrane 
trafficking and 2) the use of transmembrane domains, which can reposition the SNARE 
molecules.  
Every cellular compartment of the secretory route contains a specific set of SNARE 
molecules. They are called v-SNARE or t-SNARE molecules (vesicle or target). SNARE 
molecules are transmembrane molecules which direct membrane trafficking in eukaryotic 
cells 43. More recently, SNAREs are classified into Q and R SNAREs based on structural 
features. This nomenclature is more precise since certain SNARE molecules act as both v- 
and t-SNAREs depending on the direction of vesicle flow. Besides transmembrane 
domains which serve as membrane anchors also lipid modifications like palmitoylation or 
farnesylation 44, 45 occur. Combinations of transmembrane domains and palmitoylation, 
preventing degradation of the SNARE, are also reported 46. SNARE molecules are 
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characterized by the so-called SNARE motif which is a conserved region of approximately 
65 amino acids, this region also determines the specificity of the SNARE molecule 47. This 
important feature enables modification of the specificity of the SNARE molecules by 
adapting the SNARE motifs. By fusing these SNARE motifs to transmembrane domains of 
other proteins it becomes possible to relocalize the SNARE motifs and modify membrane 
trafficking in eukaryotic systems 42. Hu et al. showed that, by flipping SNARE molecules 
to the outside of cell membranes, it is possible to fuse these cells, again indicating that 
SNARE molecules and especially the SNARE motifs are determining the specificity of 
fusion of membranes 48.The N-terminal domains of SNAREs are thought to act like a 
zipper which acts from the N-terminus towards the transmembrane domain thereby 
bringing the membranes in close proximity followed by the actual fusion. This model has 
been reviewed in an excellent paper 43. Most research on SNARE molecules has been 
performed in the field of neuronal cells 49, 50, in relation to synaptic vesicle transport. In 
Saccharomyces cerevisiae a clear set of orthologous proteins can be found as well as in 
Aspergillus niger (see Figure 5).  
The concept of SNARE-pin formation has been reviewed by Jahn 51, 43. In this concept, four 
helices are interacting to form a so called SNARE pin. The helices are named Q- and R-
helices, determined by the glutamine and arginine residues which are participating. The 
glutamine residues are specified further as Qa, Qb, and Qc. These SNARE complexes are 
very efficient in mediating membrane fusion. Recently, it was shown very elegantly, by 
FRET studies, that one SNARE complex is sufficient to enforce membrane fusion 52. Again, 
this indicates that modification of these SNARE complexes can have a direct effect on vesicle 
transport. 
It has been described that N-terminal domains and SNARE motifs determine the 
functionality of SNARE proteins 53. The functions of the transmembrane domains are not 
very well known, but one obvious function would be to target and anchor the SNARE in the 
correct membrane. By using the cytosolic domain of the SNARE and fusing this part to a 
transmembrane domain of a protein which is located in a different membrane it is possible 
to engineer membrane trafficking in vivo 42. 
To reposition the SNARE molecules a transmembrane domain is needed of a protein which 
is located on the vesicles which need to be modified in order to engineer membrane 
trafficking. The protein of which the transmembrane part is used should have the N-
terminus at the cytosolic side (i.e. surface) of the membrane. The concept of this approach is 
depicted in Figure 3. 
The transmembrane domains of proteins as tools for relocalization of SNARE molecules 
should be selected carefully. For the proof of principle which was aimed at transforming 
peroxisomes into secretory vesicles in order to secrete proteins which were located in the 
peroxisome, the A. niger ortholog of a peroxisomal membrane protein described in 
Arabidopsis named PMP22 54, 55 was used. The final topology of the fusion protein SNARE-
membrane anchor is important. The N-terminal domains and SNARE motifs should be 
positioned at the cytosolic side of the vesicle in order to interact with their SNARE partner. 
In order to enable peroxisomal fusion with the plasma membrane, it was crucial to identify a 
peroxisomal membrane anchor, which could be used to decorate the peroxisome with 
proteins involved in membrane fusion. In order to determine whether peroxisomal 
membrane proteins have the correct topology we performed topology predictions at the  
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Fig. 3. The membrane trafficking engineering concept. The concept is based on using a 
cytosolic SNARE domain (green) which is located on a secretory vesicle A. This SNARE 
domain is fused to a transmembrane domain (grey) of a transmembrane protein originally 
located on vesicle B. The fusion protein (grey-green) should then be localized at vesicle B, 
and transforms this vesicle into a secretory vesicle B. 
CBS prediction server, as shown in Figure 4 for the PMP22 ortholog of A. niger 
(An04g09130). 
The peroxisomal membrane protein PMP22 has been studied in CHO cells 56, in Arabidopsis 
55, and in COS cells 57. All these studies give a description of the membrane topology of 
PMP22, PMP22 contains 4 TMDs and has the N- and C-termini placed at the cytosolic side of 
the peroxisome. The precise role of PMP22 is not known. PMP22 contains two peroxisomal 
targeting regions with almost identical basic clusters which interact with PEX19 57. The N-
terminus of PMP22 is placed towards the cytosolic side and this topology makes PMP22 
useful for v-SNARE fusions at the N-terminus. To determine if PMP22 localizes to the 
peroxisomes a GFP-PMP22 fusion was constructed and expressed in A. niger 42. Using 
fluorescence microscopy the localization of GFP-PMP22 was determined. The pattern of the 
GFP-PMP22 fusion is similar to the GFP-SKL punctuated pattern, which indicates that the 
PMP22 can be used as peroxisomal membrane anchor 42. 
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MSAKFQDEAVTSIREDTKELVHKVGNRLTGDGYLALYLRQLQSNPLRTKMLTSGVLSSLQEILASWIA
HDVSKHGHYFSARVPKMALYGMFISAPLGHFLIGILQRVFAGRTSIKAKILQILASNLLVSPIQNAVYL
CCMAVIAGARTFHQVRATVRAGFMPVMKVSWVTSPIALAFAQKFLPEHTWVPFFNIVGFVIGTYVNT
HTKKKRLEALRKCGLPDMVG 
Fig. 4. Predicted topology and sequence of the PMP22 ortholog in A. niger (An04g09130). 
The upper panel displays the predicted topology of the PMP22 ortholog by the CBS 
prediction servers (http://www.cbs.dtu.dk/services/). Four transmembrane domains are 
predicted, although the TMD between aa 150 and 175 does not exceed the threshold and 
therefore, 3 TMD are possible as well. It is clear that in both scenarios the N terminus of 
An04g09130 is positioned towards the outside (cytosolic side) of the vesicle. The lower panel 
displays the aminoacid sequence of the A. niger ortholog of PMP22 (An04g09130) used as 
input for the CBS prediction server TMD algorithm. 
Crucial in this engineering approach is the final orientation of the novel chimeric SNARE 
molecule, the SNARE domain should be positioned on the outer side (i.e. surface) of the 
vesicle as shown in Figure 3. The resulting vesicles are decorated with a set of alternative 
SNARE molecules which can enable fusion of these vesicles with other cellular 
compartments which contain the appropriate target SNAREs. 
Peroxisomes decorated with SNARE proteins have been used as alternative vesicles for 
transport of intracellular proteins 42. The use of peroxisomes as alternative vesicles for 
secretion of proteins which are normally located in the cytosol can be justified by several 
observations. Peroxisomes are organelles with a single membrane 59 and a very elegant 
publication shows convincing evidence that peroxisomes originate at the ER 60. In addition, 
the identification of the small GTPase Rho1p as being localized on peroxisomes by 
interaction of the peroxisomal membrane protein Pex25p again indicates a link of 
peroxisomes with the secretory machinery 61, since Rho1p is known to play a role in actin 
reorganization and membrane dynamics 62, 63. In yeast, polarized growth is regulated by 
Rho1p 64, and also in fungal systems the link between Rho1 and polarized growth has been 
confirmed 65 in the filamentous fungus A. niger, polarized growth is linked to secretion of 
proteins 66.  
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Fig. 5. Overview on SNARE molecules in Aspergillus niger and their orthologs in 
Saccharomyces cerevisiae. This overview is based on the A. niger sequencing work and the 
supplementary material of the resulting publication 58. In green, the vesicle flow form Golgi 
towards cell membrane is shown, dark blue indicates vesicle flow from ER towards Golgi 
and the orange vesicles are representing retrograde transport form Golgi towards ER. 
Finally, the light blue vesicles are representing vacuolar vesicle flow derived from the Golgi 
apparatus. 
More recent papers also very clearly showed that peroxisomes originate from the 
endoplasmic reticulum 60, 67, 68-70. The recent finding that insertion of some peroxisomal 
membrane proteins occurs already at the ER 71 clearly underpins that peroxisomes are 
linked to the secretory pathway in the eukaryotic cell. However, the same study mentioned 
that no conventional signal sequences can be found in a set of Peroxisomal Membrane 
Proteins (PMP) in S. cerevisiae. A possible mechanism could be that Pex19p, which is 
described as a chaperone for proper insertion of PMP into peroxisomes 72-74 also acts a 
receptor for peroxisomal membrane proteins which are inserted at the ER membrane and 
become part of peroxisomes at a later stage. An alternative model could be that Pex19p is 
involved in de budding process of (pre)peroxisomes from the ER where PMP have been 
already inserted. This yields an interesting model which strongly suggest that peroxisomes 
are derivatives of the secretory pathway. It has been reported that the transportation of 
peroxisomes in Arabidopsis by actin filaments is dependent on MYA2 (Myosin XI isoform) 75, 
similar to the transportation of secretory vesicles. This common ground makes peroxisomes 
an attractive vehicle for transporting intracellular proteins towards the plasma membrane. 
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Fig. 6. Peroxisomes originate from the endoplasmic reticulum, taken from Tabak et al. 2003 
67. In this 3D- reconstituted SEM picture 67 which was processed in silico, the peroxisomes 
(green) are attached to the smooth ER (light blue), as a continuous membrane structure. 
Other peroxisomes have already been released from the smooth ER. Rough ER is indicated 
by dark blue and the red dots represent ribosomes on the RER. 
In addition, these organelles contain an import machinery capable of importing 
completely folded proteins 76-79, and have a controlled way of proliferation 80-82. So, 
peroxisomes have the same origin as secretory vesicles and are thus candidates for 
alternative trafficking of proteins. The first application of such an engineered secretory 
pathway would be to produce intracellular proteins which show a much broader 
spectrum of enzymatic activities compared to secreted proteins which have 
predominantly hydrolase activity (as depicted in Figure 1). Normally, the intracellular 
proteins are folded in the cytosol, are not N-glycosylated, and disulphide bridges are not 
formed in this relatively reducing environment 2. The cytosol does not contain a major 
machinery for the formation of disulphide bridges or for N-glycosylation as the ER does 
83,84. These basic differences suggest that the conventional route to secrete these 
intracellular proteins is not compatible with the folding environment, kinetics and 
modifications of these proteins. 
The demonstration of engineering membrane trafficking is based on the ability of 
peroxisomes to import completely folded proteins. The peroxisomes containing the proteins 
of interest are equipped with a v-SNARE, which is normally localized at the Golgi apparatus 
(the study of Marelli et al. 2004 did not identify SNARE-like proteins on peroxisomal 
membranes). This ensures that peroxisomes are able to bind to t-SNAREs which are 
localized at the plasmamembrane. After the formation of a so called SNARE-pin the  
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Fig. 7. Overview of the peroxicretion concept. Panel A shows the expression of SKL tagged 
proteins of interest together with the expression of SNC1-PMP22 fusion protein which are 
localized on the peroxisomal membrane. The transmembrane anchor encoded by the PMP22 
is depicted in blue, the SNC1 SNARE module is encoded by red, together they ensure the 
decoration of peroxisomes with the A. niger ortholog of the v-SNARE SNC1 at the cytosolic 
side. Panel B shows the translocation of the SKL tagged proteins into the decorated 
peroxisomes. Panel C shows the complete translocation of the SKL tagged proteins in 
peroxisomes, the formation of peroxisomes can be increased by overexpression of PEX11 
orthologs 86. Panel D shows the fusion of the peroxisomes with the plasmamembrane, using 
the ortholog of the t-SNARE SSO1 (purple). The complete SNAREpin structure is more 
complex, and is not described here for the sake of simplicity. 
peroxisomes fuse with the plasma membrane thereby releasing their luminal content. The A. 
niger ortholog of v-SNARE SNC1 (An12g07570) was placed on the peroxisome using the 
transmembrane domain of the PMP22 ortholog (An04g09130) as a membrane anchor. The 
transmembrane domain of SNC1 was omitted, the fusion protein is shown in Figure 8. It has 
been reported that this transmembrane domain of SNC1 is important for the function of 
SNC1 85, but the replacement of this TMD by the PMP22 TMD did not abolish the function 
of SNC1 (An12g07570) in A. niger 42. The replacement of the SNC1 TMD by the PMP22 
protein does not diminish the potential of SNC1 to enforce membrane fusion because the 
peroxisomal content is released extracellularly. The paper of Grote et al. 2000 85 described 
inhibition of SNC1 function when the TMD was replaced by geranylgeranyl anchors. 
Probably membrane fusion is only possible when the TMD domains of the SNARE pairs 
bring the membrane bilayers in close contact so that spontaneous membrane fusion occurs.  
Proteins which are produced by using the peroxicretion technology are C-terminally tagged 
with a PTS1 signal. The most commonly used PTS1 is SKL 87, however variations on this 
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sequence have been described as well 87. Since the Pex5p (PTS1 receptor) is highly conserved 
between yeasts and A. niger, it has been shown that SKL also functions as a PTS1 signal in A. 
niger 42. This raises possibilities for purifying the PTS1 tagged products on an affinity 
column which specifically binds PTS1 sequences. In principal nature has provided us 
already with a very efficient PTS1 binding protein Pex5p, which is the natural receptor for 
PTS1. 
 
MSEQPYDPYIPSGANGAGAGASAAQNGDPRTREIDKKIQETVDTMRSNIFKVSERGERLD
SLQDKTDNLATSAQGFRRGANRVRKQMWWKDMKMRSAKFQDEAVTSIREDTKELVHK
VGNRLTGDGYLALYLRQLQSNPLRTKMLTSGVLSSLQEILASWIAHDVSKHGHYFSARVP
KMALYGMFISAPLGHFLIGILQRVFAGRTSIKAKILQILASNLLVSPIQNAVYLCCMAVIAG
ARTFHQVRATVRAGFMPVMKVSWVTSPIALAFAQKFLPEHTWVPFFNIVGFVIGTYVNT
HTKKKRLEALRKCGLPDMVG 
Fig. 8. The SNC1-PMP22 fusion protein which enables peroxicretion. SNC1 ortholog 
sequence (no TMD)is depicted in green (based on An12g07570) the PMP22 ortholog 
sequence (based on An04g09130) is depicted in blue.  
Mutational studies to determine whether shortening of the region between SNC1 and 
PMP22, thereby placing SNC1 closer to the peroxisomal membrane, could enhance 
peroxicretion were performed by our group. This approach was partially successful, the 
most efficient peroxicretion occurred when SNC1 was linked to the full length PMP22 (318 
aa) or a truncated version of PMP22 (300 aa). When PMP22 was truncated further the 
peroxicretion decreased dramatically (< 50%). This is in contrast with a previous study 88, 
which predicts an increase of vesicle fusion when the hinge region of the v-SNARE and the 
TMD domain is shortened. This discrepancy is most likely caused by the unnatural TMD of 
the SNC1-PMP22 fusion protein. The TMD of PMP22 was not evolutionarily selected for 
efficient membrane fusion. Moreover, the localization information of PMP22 is most likely 
positioned in this hinge region. GFP fusions with the different truncated PMP22 constructs 
showed a localization, which is not unambiguously peroxisomal. This indicated (partial) 
mis-localization of SNC1-PMP22 fusion products when PMP22 is truncated to less than 300 
aa, explaining the dramatic decrease of peroxicretion.  
Additional modifications to fine-tune the peroxicretion concept can be foreseen, like 
rebuilding the peroxisome in such a way that all components of the secretory vesicles 
(proteins and lipids) are present on the peroxisome, making them efficient cell organelles for 
peroxicretion. Subcellular proteomics could supply us with these leads. One of the most 
promising options is to use Sec4p a protein involved in SNARE-pin formation. Sec4p is a 
Rab-GTPase which plays an important role in polarized secretion by tethering secretory 
vesicles to the plasmamembrane 89, 90. Sec4p is localized at Golgi-derived vesicles with a 
geranylgeranyl anchor. Sec4p GEF (Sec2p) and Sec4p GAP (Msb3p and Msb4p) are 
described and are controlling the activity of Sec4p 91. This makes Sec4p and its partners 
potential leads for improving the peroxicretion technology. 
In the quest for alternative secretory routes the peroxicretion concept was developed 42, 
which shows that it is possible to redirect peroxisomes to the cell membrane where they are 
able to fuse and release their cargo in the extracellular medium, as shown in Figure 7. The 
peroxisomes can be loaded with intracellular enzymes by adding a C terminal peroxisomal 
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signal sequence like SKL. A combination of the peroxicretion approach with more 
conventional approaches to improve protein production like removal of proteases and 
increasing folding capacity of, in this case, the cytosol may further improve protein 
production. This proof of principle shows that by relocalizing the SNARE molecules to 
alternative compartments, it is possible to redirect vesicle trafficking in cells, which could 
also enable production of toxic compounds in micro organisms. This exciting possibility of 
constructing chimeric proteins of a specific membrane anchor with a specific SNARE 
functionality is an important tool to engineer membrane trafficking.  
Moreover, it can also be hypothesized that due to the modified peroxisomes the complete 
biomass could now be used for production of enzymes, and not only the hyphal tips as is 
being suggested for normal secretory proteins 92. A speculative idea would be to determine the 
components that allow the peroxisomes to utilize all of the biomass to release their content into 
the medium and adjust the conventional secretory vesicles in a similar way which would 
enable secretion of secretory proteins using the complete biomass instead of just the hyphal 
tips. Using this approach we could even increase fermentation yields of secretory proteins. 
5. Designing a robust and versatile cell factory, an outlook 
The cell factory of the future should be able to produce a wide range of proteins and 
metabolites with high productivities and yields in a robust process. It is clear that current 
strategies contribute in an incremental way, which is important to make the bioprocess 
economically feasible. In order to expand the product range and design a truly versatile cell 
factory more innovative approaches are needed. Until now, membrane engineering has 
hardly been used as an additional tool for designing cell factories. Recent developments 
have shown that membrane engineering can be a key for designing a truly versatile cell 
factory. The potential of this approach is enormous, especially in combination with 
conventional strategies. 
In this era of synthetic biology were bio-bricks are used to engineer microbes for new 
functionalities the concept of membrane trafficking engineering is very well positioned. It 
enables a true engineering methodology for intracellular trafficking thereby unlocking a 
complementary approach to already applied strategies like genetic devices based on bio-
bricks. In addition, the availability of -omics technologies will function as a starting platform 
for further fine-tuning of the membrane engineering concept. Based on this holistic 
approach more key components will be identified which can be used to increase the 
efficiency of membrane engineering and the application of engineered membranes in 
microbial cell factories.  
This quest for further fine-tuning will be exciting and will have academic impact as well. 
The membrane trafficking engineering concept can serve the academic society with a new 
way of studying the complex vesicle flow in biological systems. By combining different 
components of the secretory pathway into novel chimeric proteins with new functionalities 
a detailed overview is within reach which can describe the molecular details of the protein 
secretion mechanism.  
This is a major challenge and as with any technology the combined effort of industry and 
academia can result in significant progress when strong interaction and mutual creativity 
are applied and recognized. 
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